HOW FRAGILE ARE THE CLINICAL TRIALS SUPPORTING APPROVAL OF NOVEL ANTICANCER MEDICINES

A new article, recently published in The Lancet Oncology, raises a question of the fragility of phase 3, randomized, controlled trials supporting anticancer drugs that were approved by the FDA...

Read More


Interview with Andrei Gudkov

Interview with Andrei Gudkov, Ph.D., D.Sci., Senior Vice President, Research Technology and Innovation, Chair, Cell Stress Biology, Roswell Park Comprehensive Cancer Center (Buffalo, USA), Member of RakFond's Scientific Advisory Board... Learn about the relationship between cancer and evolution, what the scientists may be proud of, and where the curiosity leads us...

Read More


PRESENTATION OF THE STUDY SUPPORTED BY RAKFOND AT 2019 ASCO ANNUAL MEETING

Final results of the randomized phase II trial of olanzapine versus aprepitant in patients receiving high-emetogenic chemotherapy were presented by its author Dr. Alexey Rumyantsev at the Annual Meeting of the American Society of Clinical Oncology (ASCO) during the Symptoms and Survivorship session on June 3, 2019, in Chicago, USA...

Read More


SUBMISSION OF APPLICATIONS FOR THE CLINICAL RESEARCH PROJECTS COMPETITION IS CLOSED

Ten full applications were received in response to the Request For Proposals for the RakFond's competition of clinical research projects in oncology...

Read More


WHAT IS CLINICAL RESEARCH

RakFond's SAB Member Professor Nikolay Zhukov, MD, DSci, explains in this video what clinical research is, he describes different types of clinical studies, what they provide to medical doctors, and why taking part in clinical trials is important for patients...

Read More


NEWS OF THE 2019 ASCO ANNUAL MEETING: PART II

Compiled by Alexey Rumyantsev, MD in the Department of Clinical Pharmacology and Chemotherapy of the N.N. Blokhin National Medical Research Center of Oncology, RakFond’s grantee, IDEA (International Development and Education Award) awardee and this year’s presenter at the ASCO meeting...

Read More


NEWS OF THE 2019 ASCO ANNUAL MEETING: PART I

The American Society of Clinical Oncology (ASCO) Annual Meeting took place at the beginning of June in Chicago, USA. Alexey Rumyantsev, MD in the Department of Clinical Pharmacology and Chemotherapy of the N.N. Blokhin National Medical Research Center of Oncology, RakFond’s grantee, IDEA (International Development and Education Award) awardee and this year’s presenter at the ASCO meeting, has put together the main news of the meeting...

Read More


One week left to register applications for the competition of clinical research projects in oncology

Applications submission is open for proposals of randomized clinical trials in oncology and related areas. Application due date is July 01, 2019. Online pre-registration is required by June 20, 2019...

Read More


RUSSIAN ONCOLOGISTS PROPOSED A NEW WAY TO PREVENT CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING

Results of the clinical trial are presented today at the largest oncology ASCO meeting in Chicago, USA...

Read More


RESULTS OF THE SUPPORTED RESEARCH ON LUNG CANCER DIAGNOSTIC PLATFORM DEVELOPMENT

В Санкт-Петербурге завершилось второе исследование, поддержанное исследовательским грантом RUSSCO и РакФонда для молодых ученых и начинающих исследователей в области онкологии... Результаты проведенного исследования будут в ближайшее время опубликованы в специализированных изданиях...

Read More